Fisetin Inhibits Osteoclastogenesis Through Prevention of RANKL-Induced ROS Production by Nrf2-Mediated Up-Regulation of Phase II Antioxidant Enzymes
Journal of Pharmacological Sciences - Japan
doi 10.1254/jphs.12243fp
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Japanese Pharmacological Society